Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum phosphatidylinositol as a biomarker for bipolar disorder liability.

Bipolar disorders - 1 Mar 2017

Knowles Emma Em, Meikle Peter J, Huynh Kevin, Göring Harald Hh, Olvera Rene L, Mathias Samuel R, Duggirala Ravi, Almasy Laura, Blangero John, Curran Joanne E, Glahn David C

Abstract excerpt

OBJECTIVES: Individuals with bipolar disorder (BPD) exhibit alterations in their phospholipid levels. It is unclear whether these alterations are a secondary consequence of illness state, or if phospholipids and illness risk overlap genetically. If the latter were true, then phospholipids might provide key insights into the pathophysiology of the illness. Therefore, we rank-ordered phospholipid classes by their...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bipolar Disorder
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endophenotypes

Share to Family

Share to Phosphatidylinositols

Share to Psychiatric Status Rating Scales

Share to Quantitative Trait, Heritable

Share to Tandem Mass Spectrometry

Source

Open in PubMed Open full text

Identifiers

PMID: 28230325
DOI: 10.1111/bdi.12468
PMCID: PMC5798864

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum phosphatidylinositol as a biomarker for bipolar disorder liability.PMID 28230325Read ↗

The lipidome in major depressive disorder: Shared genetic influence for ether-phosphatidylcholines, a plasma-based phenotype related to inflammation, and disease risk.Semantic proximity Read ↗

Plasma Lipid Alterations Track Multidimensional Psychosis Severity Across Diagnostic BoundariesSemantic proximity Read ↗

Plasma Lipid Alterations and Polygenic Risk Track Multidimensional Psychosis Severity Across Classical Diagnostic BoundariesSemantic proximity Read ↗

Phenotypic Associations and Shared Genetic Etiology between Bipolar Disorder and Cardiometabolic TraitsSemantic proximity Read ↗

A Metabolome-Wide Mendelian Randomization Study Identifies Dysregulated Arachidonic Acid Synthesis as a Potential Causal Risk Factor for Bipolar Disorder.Semantic proximity Read ↗

Familial risk for bipolar I disorder is associated with erythrocyte omega-3 polyunsaturated fatty acid deficits in youth with attention-deficit hyperactivity disorder.Semantic proximity Read ↗

Dysregulated lipid metabolism precedes onset of psychosis in people at clinical high riskSemantic proximity Read ↗

Bipolar disorder and its relation to major psychiatric disorders: a family‐based study in the <scp>S</scp>wedish populationSemantic proximity Read ↗

Association analysis between polymorphisms in the myo-inositol monophosphatase 2 (IMPA2) gene and bipolar disorder.Semantic proximity Read ↗

Early identification and high-risk strategies for bipolar disorder.Semantic proximity Read ↗

The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder.Semantic proximity Read ↗

Association between polymorphisms in the metallophosphoesterase (MPPE1) gene and bipolar disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.